Genetic Epidemiology of Chagas Disease

Advances in Parasitology

Volumn 75, Issue , 2011, Pages 147-167

  Williams Blangero, Sarah ^a   VandeBerg, John L ^a,b   Blangero, John ^a   Corrêa Oliveira, Rodrigo ^c,d  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d Instituto Nacional de Ciencia e Tecnologia em Doenças Tropicais INCTDT   (Brazil)

Author keywords

Chagas disease; Genotype by environment interaction; Heritability; HLA; QTL; Trypanosoma cruzi

Indexed keywords

BOOK; CHAGAS DISEASE; ELECTROCARDIOGRAPHY; GENE CLUSTER; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HEREDITY; HERITABILITY; HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

TRYPANOSOMA CRUZI;

EID: 79960977710     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385863-4.00007-1     Document Type: Chapter

References (81)

1. Aguilar H.M., Abad-Franch F., Pinto Dias J.C., Junqueira A.C.V., Coura J.R. Chagas disease in the Amazon region. Mem. Inst. Oswaldo Cruz 2007, 102:47-55.
2. Almasy L.A., Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am. J. Hum. Genet. 1998, 62:1198-1211.
3. Añez N., Crisante G., Maia da Silva F., Rojas A., Carrasco H., Umezawa W.S., et al. Predominance of lineage I among Trypanosoma cruzi isolates from Venezuelan patients with different clinical profiles of acute Chagas disease. Trop. Med. Int. Health 2004, 9:1319-1326.
4. Barbosa C.A.A., Morton N.E., Rao D.C., Krieger H. Biological and cultural determinants of immunoglobulin levels in a Brazilian population with Chagas' disease. Hum. Genet. 1981, 59:161-163.
5. Beard C.B., Pye G., Steurer F.J., Rodrigues R., Campman R., Peterson A.T., et al. Chagas disease in a domestic transmission cycle, southern Texas, USA. Emerg. Infect. Dis. 2003, 9:103-105.
6. Bern C., Montgomery S.P. An estimate of the burden of Chagas disease in the United States. Clin. Infect. Dis. 2009, 49:e52-e254.
7. Biolo A., Ribeiro A.L., Clausell N. Chagas cardiomyopathy-where do we stand after a hundred years?. Prog. Cardiovasc. Dis. 2010, 52:300-316.
8. Blackwell J.M., Jamieson S.E., Burgner D. HLA and infectious diseases. Clin. Microbiol. Rev. 2009, 22:370-385.
9. Blangero J. Statistical genetic approaches to human adaptability. Hum. Biol. 1993, 65:941-946.
10. Borges J.S., Machada de Assis G.F., Gomes L.V., Dias J.C.P., Pinto I.D.M., Martins-Filho O.A., et al. Seroprevalence of Chagas disease in school children from two municipalities of Jequitinhonha Valley, Minas Gerais, Brazil: six years following the onset of epidemiological surveillance. Rev. Inst. Med. Trop. Sao Paulo 2006, 48:81-86.
11. Briceño-Leon R. Chagas disease and globalization of the Amazon. Cad. Saúde Pública 2007, 23(Suppl. 1):S33-S40.
12. Busch M.P., Kleinman S.H., Nemo G.J. Current and emerging infectious risks of blood transfusions. J. Am. Med. Assoc. 2003, 289:959-961.
13. Buscaglia C.A., Di Noia J.M. Trypanosoma cruzi clonal diversity and the epidemiology of Chagas? disease. Microbes Infect. 2003, 5:419-427.
14. Calzada J.E., Pineda V., Garisto J.D., Samudio F., Santamaria A.M., Saldaña A. Human trypanosomiasis in the eastern region of the Panama province: new endemic areas for Chagas disease. Am. J. Trop. Med. Hyg. 2010, 82:580-582.
15. Campbell D.A., Westenberger S.J., Strum N.R. The determinants of Chagas disease: connecting parasite and host genetics. Curr. Mol. Med. 2004, 4:549-562.
16. Castro J.A., de Mecca M.M., Bartel L.C. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis). Hum. Exp. Toxicol. 2006, 25:471-479.
17. Coll-Cardenas R., Espinoza-Gomez F., Maldonado-Rodriguez A., Reyes-Lopez P.A., Huerta-Viera M., Rojas-Larios F. Active transmission of human Chagas disease in Colima Mexico. Mem. Inst. Oswaldo Cruz 2004, 99:363-368.
18. Colorado I.A., Acquatella H., Catalioti F., Fernandez M.T., Layrisse Z. HLA class II DRB1, DPB1 polymorphisms and cardiomyopathy due to Trypanosoma cruzi chronic infection. Hum. Immunol. 2000, 61:320-325.
19. Cruz-Robles D., Reyes P.A., Monteon-Padilla V.M., Ortiz-Muniz A.R., Varga-Alarcon G. MHC class I and class II genes in Mexican patients with Chagas disease. Hum. Immunol. 2004, 65:60-65.
20. Cruz-Robles D., Chávez-Gonzáles J.P., Cavazos-Quero M.M., Pérez-Méndez O., Reyes P.A., Vargas-Alarcón G. Association between IL-1B and IL-1RN gene polymorphisms and Chagas' disease development susceptibility. Immunol. Invest. 2009, 38:231-239.
21. Drigo S.A., Cunha-Neto E., Ianni B., Cardosa M.R., Braga P.E., Fae F.C., et al. TNF gene polymorphisms are associated with reduced survival in severe Chagas disease cardiomyopathy patients. Microbes Infect. 2006, 8:598-603.
22. Drigo S.A., Cunha-Neto E., Ianni B., Mady C., Faé K.C., Buck P., et al. Lack of association of tumor necrosis factor-α polymorphisms with Chagas disease in Brazilian patients. Immunol. Lett. 2007, 108:109-111.
23. Dutra W.O., Rocha M.O.C., Teixeira M.M. The clinical immunology of Chagas disease. Trends Parasitol. 2005, 21:581-587.
24. Fernandez-Mestre M.T., Layrisse Z., Mantagnani S., Acquatella H., Cataloiti F., Matos M., et al. Influence of HLA class II polymorphism in chronic Chagas disease. Parasite Immunol. 1998, 20:197-203.
25. Flórez O., Zafra G., Morillo C., Martín J., González C.I. Interleukin-1 gene cluster polymorphism in Chagas disease in a Colombian case-control study. Hum. Immunol. 2006, 67:741-748.
26. García Borras S., Racca L., Cotorruelo C., Biondi C., Beloscar J., Racca A. Distribution of HLA-DRB1 alleles in Argentinean patients with Chagas disease cardiomyopathy. Immunol. Invest. 2009, 38:268-275.
27. Garcia-Zapata M.T.A., Marsden P.D. Chagas disease. Clin. Trop. Med. Commun. Dis. 1986, 1:557-585.
28. Garg N., Bhatia V. Current status and future prospects for a vaccine against American trypanosomiasis. Exp. Rev. Vaccines 2005, 4:867-880.
29. Goldbaum M., Ajimura F.Y., Litvoc J., Alves de Carvalho S., Eluf-Neto J. American trypanosomiasis and electrocardiographic alterations among industrial works in São Paulo Brazil. Rev. Inst. Med. Trop. Sao Paulo 2004, 46:299-302.
30. Grijalva M.J., Escalante L., Paredes R.A., Costales J.A., Padilla A., Rowland E.C., et al. Seroprevalence and risk factors for Trypanosoma cruzi infection in the Amazon region of Ecuador. Am. J. Trop. Med. Hyg. 2003, 69:380-385.
31. Gurtler R.E., Cecere M.C., Lauricella M.A., Petersen R.M., Chuit R., Segura E.L., Cohen J.E. Incidence of Trypanosoma cruzi infection among children following domestic reinfection after insecticide spraying in rural northwestern Argentina. Am. J. Trop. Med. Hyg. 2005, 73:95-103.
32. Jorge M.T., Macedo T.A., Janones R.S., Carizzi D.P., Heredia R.A., Acha R.E. Types of arrhythmia among cases of American trypanosomiasis compared with those in other cardiology patients. Ann. Trop. Med. Parasitol. 2003, 97:139-148.
33. Kirchhoff L.V. American trypanosomiasis (Chagas' disease). Tropical Infectious Diseases: Principles, Pathogens, and Practice 1999, 785-796. Churchill Livingstone, New York. R.L. Guerrant, D.H. Walker, P.F. Weller (Eds.).
34. Layrisse Z., Fernandez M.T., Montagnani D., Matos M., Balbas O., Herrera F., et al. HLA-C(* )03 is a risk factor for cardiomyopathy in Chagas disease. Hum. Immunol. 2000, 61:925-929.
35. Leiby D.A., Herron R.M., Read E.J., Lenes B.A., Stumpf R.J. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 2002, 42:549-555.
36. Lescure F.X., LeCoup G., Ferilij H., Develoux M., Paris L., Brutus L., et al. Chagas disease: changes in knowledge and management. Lancet Infect. Dis. 2010, 10:556-570.
37. Llop E.R., Rothhammer F., Acuña M., Apt W., Arribada A. Antigenos HLA en cariopatas chagasicos: nueva evidence basada en un analisis de casos y controles. Rev. Med. Chile 1991, 119:633-636.
38. Macedo A.M., Machado C.R., Oliveira R.P., Pena S.D.J. Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of Chagas disease. Mem. Inst. Oswaldo Cruz 2004, 99:1-12.
39. Maguire J.H., Hoff R., Sherlock I., Guimaraes A.C., Sleigh A.C., Ramos N.B., et al. Cardiac morbidity and mortality due to Chagas disease: prospective electrocardiographic study of a Brazilian community. Circulation 1987, 75:1140-1145.
40. Manoel-Caetano F.S., Silva A.E. Implications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease. Cad. Saude Publica Rio de Janeiro 2007, 23:2263-2274.
41. McCarthy M. American Red Cross to screen blood for Chagas disease. Lancet 2003, 362:1988.
42. Miles M.A., Llewellyn M.S., Lewis M.D., Yeo M., Baleela R., Fitzpatrick S., et al. The molecular epidemiology and phylogeography of Trypanosoma cruzi and parallel research on Leishmania: looking back and to the future. Parasitology 2009, 136:1509-1528.
43. Moreno M., Silva E.L., Ramirez L.E., Palacio L.G., Rivera D., Arcos-Burgos M. Chagas disease susceptibility/resistance: linkage disequilibrium suggests epistasis between major histocompatibility complex and interleukin 10. Tissue Antigens 2004, 64:18-24.
44. Mott K.E., Lehman J.S., Hoff R., Morrow R.H., Muniz T.M., Sherlock I., et al. The epidemiology and household distribution of seroreactivity to Trypanosoma cruzi in a rural community in northeast Brazil. Am. J. Trop. Med. Hyg. 1976, 25:552-562.
45. Nieto A., Beraun Y., Collado M.D., Caballero A., Alonso A., Gonzalez A., et al. HLA haplotypes are associated with differential susceptibility to Trypanosoma cruzi infection. Tissue Antigens 2000, 55:195-198.
46. Norman F.F., Pérez de Ayala A., Pérez-Molina J.A., Monge-Maillo B., Zamarrón P., López-Vélez R. Neglected tropical diseases outside the tropics. PLoS Negl. Trop. Dis. 2010, 4:e762.
47. Ohlstein W.H., Ruffolo R.R., Elliott J.D. Drug discovery in the next millennium. Ann. Rev. Pharmacol. Toxicol. 2000, 40:177-191.
48. Pinto A.Y.N., Valente S.A.S., Valente V.C. Emerging acute Chagas disease in Amazonian Brazil: case reports with serious cardiac involvement. Braz. J. Infect. Dis. 2004, 8:454-460.
49. Prata A. Clinical and epidemiological aspects of Chagas' disease. Lancet Infect. Dis. 2001, 1:92-100.
50. Ramasawmy R., Cunha-Neto E., Fae K.C., Martello F.G., Müller N.G., Cavalcanti V.L., et al. The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human Chagas disease. Clin. Infect. Dis. 2006, 43:305-311.
51. Ramasawmy R., Fae K.C., Cunha-Neto E., Müller N.G., Cavalcanti V.L., Ferreira R.C., et al. Polymorphisms in the gene for lymphotoxin-alpha predispose to chronic Chagas cardiomyopathy. J. Infect. Dis. 2007, 196:1836-1843.
52. Ramasawmy R., Fae K.C., Cunha-Neto E., Borba S.C., Ianni B., Mady C., et al. Variants in the promoter region of IKBL/NFKBIL1 gene may mark susceptibility to the development of chronic Chagas' cardiomyopathy among Trypanosoma cruzi-infected individuals. Mol. Immunol. 2008, 45:283-288.
53. Ramasawmy R., Cunha-Neto E., Fae K.C., Borba S.C.P., Teixeira P.C., Ferreira S.C.P., et al. Heterozygosity for the A180L variant of MAL/TIRAP, a gene expressing an adaptor protein in the toll-like receptor pathway, is associated with lower risk of developing chronic Chagas cardiomyopathy. J. Infect. Dis. 2009, 199:1838-1845.
54. Rangel-Flores H., Sánchez B., Mendoza-Duarte J., Barnabé C., Brenière F.S., Ramos C., et al. Serologic and parasitologic demonstration of Trypanosoma cruzi infections in an urban area of central Mexico: correlation with electrocardiographic alterations. Am. J. Trop. Med. Hyg. 2001, 65:887-895.
55. Rassi A., Rassi A., Marin-Neto J.A. Chagas disease. Lancet 2010, 375:1388-1402.
56. Rizzo N.R., Arana B.A., Diaz A., Cordon-Rosales C., Klein R.W., Powell M.R. Seroprevalence of Trypanosoma cruzi infection among school-age children in the endemic area of Guatamala. Am. J. Trop. Med. Hyg. 2003, 68:678-682.
57. Rodriguez Coura J., de Castro S.L. A critical review on Chagas disease chemotherapy. Mem. Inst. Oswaldo Cruz 2002, 97:3-24.
58. Salles G., Xavier S., Sousa A., Hasslocher-Moreno A., Cardosa C. Prognostic value of QT interval parameters for mortality risk stratification in Chagas disease: results of a long-term follow-up study. Circulation 2003, 108:305-312.
59. Salles G., Xavier S., Sousa A., Hasslocher-Moreno A., Cardosa C. T-wave axis deviation as an independent predictor of mortality in chronic Chagas disease. Am. J. Cardiol. 2004, 93:1136-1140.
60. Sanchez-Sancho F., Campillo N.E., Páez J.A. Chagas disease: progress and new perspectives. Curr. Med. Chem. 2010, 17:423-452.
61. Sarkar S., Strutz S.E., Frank D.M., Rivaldi C.L., Sissel N., Sanchez-Cordero V. Chagas disease risk in Texas. PLoS Negl. Trop. Dis. 2010, 4:e836.
62. Schadt E.E., Monks S.A., Friend S.H. A new paradigm for drug discovery: integrating clinical, genetic, genomic, and molecular phenotype data to identify drug targets. Drug Discov. Des. 2003, 31:437-443.
63. Silva-Grecco R.L., Balarin M.A., Correia D., Prata A., Rodrigues V. Familial analysis of seropositivity to Trypanosoma cruzi and of clinical forms of Chagas disease. Am. J. Trop. Med. Hyg. 2010, 82:45-48.
64. Sosa-Hurado F., Mazariego-Aranda M., Hernandez-Becerril N., Garza-Murillo V., Cardenas M., Reyes P.A., et al. Electrocardiographic findings in Mexican chagasic subjects living in high and low endemic regions of Trypanosoma cruzi infection. Mem. Inst. Oswaldo Cruz 2003, 98:605-610.
65. Sturm N.R., Vargas N.S., Westenberger S.J., Zingales B., Campbell D.A. Evidence for multiple hybrid groups in Trypanosoma cruzi. Int. J. Parasitol. 2003, 33:269-279.
66. Tanowitz H.B., Machado F.S., Jelicks L.A., Shirani J., Campos de Carvalho A.C., Spray D.C., et al. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog. Cardiovasc. Dis. 2009, 51:524-539.
67. Teixeira A.R.L., Cordoba J.C., Maior I.S., Solorzano E. Chagas disease: lymphoma growth in rabbits treated with benznidazole. Am. J. Trop. Med. Hyg. 1990, 43:146-158.
68. Teixeira A.R.L., Silva R., Neto E.C., Santano J.M., Rizzo L.V. Malignant, non-Hodgkin's lymphoma in Trypanosoma cruzi infected rabbits treated with nitroarenes. J. Comp. Pathol. 1990, 103:37-48.
69. Tibayrenc M. Integrated genetic epidemiology of infectious diseases: the Chagas model. Mem. Inst. Oswaldo Cruz 1998, 93:577-580.
70. Tibayrenc M. Toward an integrated genetic epidemiology of parasitic protozoa and other pathogens. Ann. Rev. Genet. 1999, 33:449-477.
71. Tibayrenc M. Human genetic diversity and the epidemiology of parasitic and other transmissible diseases. Adv. Parasitol. 2007, 64:377-422.
72. Tibayrenc M. Modelling the transmission of Trypanosoma cruzi: the need for an integrated genetic epidemiological and population genomics approach. Adv. Exp. Med. Biol. 2010, 673:200-211.
73. Torres O.A., Calzada J.E., Beraún Y., Morillo C.A., González A., González C.I., et al. Role of the IFNG +874T/A polymorphism in Chagas disease in a Columbian population. Infect. Genet. Evol. 2010, 10:682-685.
74. Urbina J.A., Docampo R. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol. 2003, 19:495-501.
75. WHO Chagas (American trypanosomiasis) fact sheet (revise June 2010). Weekly Epidemiol. Rec. 2010, 85(34):334-336.
76. Williams J.T., Van Eerdewegh P., Almasy L., Blangero J. Joint multipoint linkage analysis of multivariate qualitative and quantitative traits. I. Likelihood formulation and simulation results. Am. J. Hum. Genet. 1999, 65:1134-1147.
77. Williams-Blangero S., Blangero J. Collection of pedigree data for genetic analysis in isolate populations. Hum. Biol. 2006, 78:89-101.
78. Williams-Blangero S., VandeBerg J.L., Blangero J., Teixeira A.R. Genetic epidemiology of seropositivity for Trypanosoma cruzi infection in rural Goias, Brazil. Am. J. Trop. Med. Hyg. 1997, 57:538-543.
79. Williams-Blangero S., Magalhaes T., Rainwater E., Blangero J., Corrêa-Oliveira R., VandeBerg J.L. Electrocardiographic characteristics in a population with high rates of seropositivity for Trypanosoma cruzi infection. Am. J. Trop. Med. Hyg. 2007, 77:495-499.
80. Yacoub S., Birks E.J., Slavik Z., Henein M. Early detection of myocardial dysfunction in Chagas disease using novel echocardiographic indices. Trans. R. Soc. Trop. Med. Hyg. 2003, 97:528-534.
81. Zicker F., Smith P.G., Netto J.C., Oliveira R.M., Zicker E.M. Physical activity, opportunity for reinfection, and sibling history of heart disease as risk factors for Chagas? cardiopathy. Am. J. Trop. Med. Hyg. 1990, 43:498-505.